Details
Stereochemistry | RACEMIC |
Molecular Formula | C16H18N2 |
Molecular Weight | 238.3275 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CC(C2=CC=CC=C2)C3=C(C1)C(N)=CC=C3
InChI
InChIKey=XXPANQJNYNUNES-UHFFFAOYSA-N
InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3
Molecular Formula | C16H18N2 |
Molecular Weight | 238.3275 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 06:18:33 UTC 2023
by
admin
on
Sat Dec 16 06:18:33 UTC 2023
|
Record UNII |
1LGS5JRP31
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C265
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
||
|
EPA PESTICIDE CODE |
600075
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
||
|
WHO-VATC |
QN06AX04
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
||
|
WHO-ATC |
N06AX04
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL273575
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
1LGS5JRP31
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
DTXSID0023377
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
116225
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
DB04821
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
2920
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
NOMIFENSINE
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
1958
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
D009627
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
SUB09347MIG
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
C72824
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
7702
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
7500
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | RxNorm | ||
|
4528
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
24526-64-5
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
m8030
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | Merck Index | ||
|
4792
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY | |||
|
100000083568
Created by
admin on Sat Dec 16 06:18:34 UTC 2023 , Edited by admin on Sat Dec 16 06:18:34 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
TARGET -> INHIBITOR |
Due to a risk of haemolytic anaemia, the U.S. Food and Drug Administration (FDA) withdrew approval for nomifensine on March 20, 1992. Nomifensine was subsequently withdrawn from the Canadian and UK markets as well.
BINDING
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
MAJOR
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
IN VITRO
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|